The work is mostly preclinical, so any human benefit remains unconfirmed
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Accurate dosing depends on accurate measuring, and simpler math means fewer errors
Independent studies also found that several ISGs were overexpressed in islets from T1D and AAb+ patients compared to controls, following an expression pattern similar to that of islets exposed to CVB (149, 172, 173)
And if you would like another IV therapy appointment, you can request the same provider or meet any of our additional qualified and experienced providers on our team at Your Skin Prescription